Larry Lasky - Profile and Investment Details

Investor Profile

Larry Lasky is a Venture Capital, Private Equity Firm, Investor based in Sausalito, California, United States with a diverse investment portfolio that includes companies such as Calithera Biosciences, Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals, Peloton Therapeutics, Carmot Therapeutics, Kallyope, PTC Therapeutics, Seragon Pharmaceuticals, Immune Design, Sagimet BiosciencesCyterix Pharmaceuticals, Hexagon Bio, Circle Pharma, Tenaya Therapeutics, Igenica, ORIC Pharmaceuticals, Casma Therapeutics, Surrozen, Accent Therapeutics, ProNeurotech, Escient Pharmaceuticals, A2 Biotherapeutics, Effector Therapeutics, Gritstone Oncology, Revolution Medicines, OncoMed Pharmaceuticals, Neurona Therapeutics, Rapt Therapeutics, Arcus Biosciences, Plexium, Synthekine, Nurix Therapeutics, Ribon Therapeutics, Flexus Biosciences, Aragon Pharmaceuticals, . Over time, Larry Lasky has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Larry Lasky is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotechnology, Consumer Health, Electronic Health Records (EHR), Health and Hospital Services, Digital Health, Medical, Big Data, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Larry Lasky, as their portfolio suggests a familiarity and interest in this area.

Understanding Larry Lasky’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.